[1] Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276-1287.[2] 唐鹏,孟国林,王军,等.长期应用双膦酸盐类药物对老年性骨质疏松骨折愈合过程的影响[J].中国骨质疏松杂志,2012,18(4):317- 322.[3] Yoo YM, Kwag JH, Kim KH, et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. Int J Mol Sci. 2014;15(4):5874-5883.[4] Lee MG, Dong X, Liu Q, et al. Agonists of the MAS-related gene (Mrgs) orphan receptors as novel mediators of mast cell-sensory nerve interactions. J Immunol. 2008;180(4): 2251-2255.[5] Sossin WS, Fisher JM, Scheller RH. Cellular and molecular biology of neuropeptide processing and packaging. Neuron. 1989;2(5):1407-1417.[6] Kelly RB. Storage and release of neurotransmitters. Cell. 1993;72 Suppl:43-53.[7] Harada N, Okajima K. Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans. Growth Horm IGF Res. 2007;17(2):171-176.[8] Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983;304(5922): 129-135.[9] Zaidi M, Chambers TJ, Gaines Das RE, et al. A direct action of human calcitonin gene-related peptide on isolated osteoclasts. J Endocrinol. 1987;115(3):511-518.[10] Deng W, St Hilaire RC, Chattergoon NN, et al. Inhibition of vascular smooth muscle cell proliferation in vitro by genetically engineered marrow stromal cells secreting calcitonin gene-related peptide. Life Sci. 2006;78(16): 1830-1838.[11] Kotobuki N, Ohgushi H. Bone tissue regeneration using stem cells. Clin Calcium. 2008;18(12):1685-1691.[12] He H, Chai J, Zhang S, et al. CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation.Mol Med Rep. 2016;13(5): 3977-3984.[13] Bäck N, Soinila S, Joh TH, et al. Catecholamine-synthesizing enzymes in the rat pituitary. An immunohistochemical study. Histochemistry. 1987;86(5):459-464.[14] Akopian A, Demulder A, Ouriaghli F, et al. Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders. Peptides. 2000; 21(4):559-564.[15] Zhou R, Yuan Z, Liu J, et al. Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells. Mol Med Rep. 2016;13(6):4689-4696.[16] Bjurholm A, Kreicbergs A, Schultzberg M, et al. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J Bone Miner Res. 1992;7(9):1011-1019.[17] Michelangeli VP, Fletcher AE, Allan EH, et al. Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells. J Bone Miner Res. 1989; 4(2):269-272.[18] De Bari C, Dell'Accio F, Karystinou A, et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum. 2008;58(1):240-250.[19] Nuttall ME, Patton AJ, Olivera DL, et al. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res. 1998;13(3):371-382.[20] Dalle Carbonare L, Valenti MT, Zanatta M, et al. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009;60(11):3356-3365.[21] Moghadam S, Engel W, Bougoussa M, et al. Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21.Fetal Diagn Ther. 1998;13(5): 291-297.[22] Rodríguez JP, Ríos S, Fernández M, et al. Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women. J Cell Biochem. 2004;92(4): 745-754.[23] Kawase T, Burns DM. Calcitonin gene-related peptide stimulates potassium efflux through adenosine triphosphate-sensitive potassium channels and produces membrane hyperpolarization in osteoblastic UMR106 cells. Endocrinology. 1998;139(8):3492-3502.[24] Vignery A, McCarthy TL. The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone. 1996;18(4): 331-335.[25] Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992;257(5066):88-91.[26] Machwate M, Zerath E, Holy X, et al. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology. 1994;134(3): 1031-1038.[27] Han J, He H. Expression and function of osteogenic genes runt-related transcription factor 2 and osterix in orthodontic tooth movement in rats. Int J Clin Exp Pathol. 2015;8(9): 11895-11900. |